Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6896

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906896)

Label Image (Lbl500906896)
Venlafaxine Hydrochloride 150 mg extended-release capsules from A-S Medication Solutions. The label includes the product name, strength, dosage form, storage instructions (80 to 77 degrees F), and package count of 90 capsules. The label also includes a QR code and barcode, lot number, and usage instructions indicating each capsule contains venlafaxine hydrochloride equivalent to 150 mg of venlafaxine.*
FDA Label Image

Figure (Venlafaxine Fig1)

Figure (Venlafaxine Fig1)
A scatter plot chart showing fold change with 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its major metabolite ODV in various special populations. The x-axis represents change relative to the reference value, and the y-axis lists populations including hepatic impairment, renal impairment, CYP2D6 metabolizer status, age, and gender.*
FDA Label Image

Figure (Venlafaxine Fig2)

Figure (Venlafaxine Fig2)
A scientific scatter plot chart illustrating the fold change and 90% confidence intervals of venlafaxine pharmacokinetic parameters (Cmax and AUC) in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The x-axis shows change relative to a reference value, with dots and error bars representing mean fold changes and confidence intervals.*
FDA Label Image

Figure (Venlafaxine Fig3)

Figure (Venlafaxine Fig3)
A scatter plot chart illustrating drug interaction effects on pharmacokinetics (PK) of various analytes. It shows fold change and 90% confidence intervals for Cmax and AUC values relative to a reference, for interacting drugs including Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride shown as a molecular diagram with rings, chains, and labeled functional groups including a methoxy group, a cyclohexane ring, and an amine group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.